0000950170-23-012066.txt : 20230406 0000950170-23-012066.hdr.sgml : 20230406 20230406160627 ACCESSION NUMBER: 0000950170-23-012066 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230404 FILED AS OF DATE: 20230406 DATE AS OF CHANGE: 20230406 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Martins Ryan CENTRAL INDEX KEY: 0001792018 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39122 FILM NUMBER: 23806211 MAIL ADDRESS: STREET 1: 535 MISSION STREET STREET 2: 14TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: 89bio, Inc. CENTRAL INDEX KEY: 0001785173 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 831114349 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 142 SANSOME STREET STREET 2: SECOND FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: (415) 432-9270 MAIL ADDRESS: STREET 1: 142 SANSOME STREET STREET 2: SECOND FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94104 4 1 ownership.xml 4 X0407 4 2023-04-04 0001785173 89bio, Inc. ETNB 0001792018 Martins Ryan C/O 89BIO, INC. 142 SANSOME STREET, 2ND FLOOR SAN FRANCISCO CA 94104 false true false false Chief Financial Officer false Common Stock 2023-04-04 4 S false 8721 14.95 D 53578 D This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on November 16, 2022 in multiple trades at prices ranging from $14.81 to $15.16. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. /s/ Ryan A. Murr, as attorney-in-fact for Ryan Martins 2023-04-06